Cobb Stuart — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Cobb Stuart is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $141K.

Profile

Cobb Stuart

Stuart Cobb is a prominent scientist and executive in the biotechnology sector, currently serving as the Chief Scientific Officer at Neurogene Inc. He has extensive experience in gene therapy and has contributed significantly to the development of innovative treatments for genetic disorders. His work has been recognized in various scientific publications and conferences.

RoleChief Scientific Officer
Notability75/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-03-17NGNENeurogene Inc.S — Open-market sale [10b5-1]148$22.08$3K
2026-03-17NGNENeurogene Inc.S — Open-market sale [10b5-1]2.7K$21.34$57K
2026-03-17NGNENeurogene Inc.S — Open-market sale [10b5-1]4.0K$20.41$81K
2026-02-24NGNENeurogene Inc.A — Grant or award16.5K$0.00

Frequently Asked Questions

Who is Cobb Stuart?

Stuart Cobb is a prominent scientist and executive in the biotechnology sector, currently serving as the Chief Scientific Officer at Neurogene Inc. He has extensive experience in gene therapy and has contributed significantly to the development of innovative treatments for genetic disorders. His work has been recognized in various scientific publications and conferences.…

Has Cobb Stuart been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($141K) across all tracked filings.

Where can I see all of Cobb Stuart's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Cobb Stuart profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.